Elevation of monocyte-platelet aggregates is an early marker of type 2 diabetes
- PMID: 24265874
- PMCID: PMC3831785
- DOI: 10.1556/IMAS.4.2012.4.2
Elevation of monocyte-platelet aggregates is an early marker of type 2 diabetes
Abstract
Background: Diabetes has been shown to be an accelerating factor in the progression of atherosclerosis. The metabolic changes in diabetes contribute to modified platelet function and enhanced leukocyte-platelet aggregate formation. The attachment of activated platelets leads to the activation of leukocytes causing enhanced cytokine production and upregulation of surface adhesion molecules. Therefore, platelet-leukocyte aggregates may be of great importance in the development of cardiovascular complications.
Materials and methods: Monocyte-platelet aggregates and monocyte Mac-1 expression were measured by flow cytometry to obtain differences between type 2 diabetic and healthy subjects. Inflammatory mediators were evaluated to assess the presence of inflammation.
Results: We found no signs of inflammation in type 2 diabetes; however, we observed enhanced aggregation level of monocytes and platelets. The expression of Mac-1 did not differ between diabetic and control subjects, but it was significantly higher on monocytes bearing platelets in both groups.
Conclusions: Elevation of monocyte-platelet aggregates is an early marker of diabetes, which precedes the signs of inflammation. Enhanced Mac-1 expression can be observed on monocytes bearing platelets, independent from the presence of diabetes.
Keywords: adhesive receptor Mac-1; cell aggregation; diabetes mellitus; inflammation; monocytes; platelets.
Figures
References
-
- Mahmoudi M, Curzen N, Gallagher PJ. Atherogenesis: the role of inflammation and infection. Histopathology. 2007 Apr;50(5):535–546. - PubMed
LinkOut - more resources
Full Text Sources
Research Materials